The PennHealthX Podcast

Latest Episodes:

Episode 6 - Gregg Khodorov and Julia Tartaglia, BEN and The Scientista Foundation Jul 20, 2017

Show notes

Gregg Khodorov and Julia Tartaglia, the co-presidents of the Biomedical Entrepreneurship Network (BEN) at the Rutgers Robert Wood Johnson Medical School, join me to discuss their interests, BEN, and The Scientista Foundation. Map: 4:00 – Gregg – getting the MBA before med school 7:11 – working for Pfizer 9:45 – undergrad at GW and deciding to go into medicine 12:15 – Julia’s path to medicine – studying human behavior, getting a post-bacc 15:45 – starting the Scientista Foundation 20:05 – barriers she faced, and barriers women face in STEM careers 24:00 – what does the Scientista Foundation do? 28:00 – BEN, the summit, and cross-disciplinary programs 37:00 – integrating business and innovation skills into medical school curriculum 45:00 – things Gregg and Julia are looking forward to in the next year Links Gregg's LinkedIn https://www.linkedin.com/in/greggkhod/ Julia's LinkedIn https://www.linkedin.com/in/juliatartaglia/ BEN Website http://benrwj.com/ BEN Facebook https://www.facebook.com/BENRWJMS/ Scientista Foundation Website http://www.scientistafoundation.com/ Wharton Business in Healthcare Conference - last year's site http://www.whcbc.org/conf2017/

Episode 5 - Nora Becker, The ACA, Women's Health, and Contraceptives Jul 20, 2017

Show notes

Nora Becker joins me to discuss her research on the ACA and it's effects on contraceptive usage. Map: 5:15 – her time at Pomona and becoming interested in public health 7:15 – deferring acceptance to Penn’s MD/PhD program to work for the Obama Campaign 10:00 – doing research at Wharton and getting a PhD not in basic science 13:00 – the value in appreciating health policy these days and how quickly health policy news/narratives/discussions can change 17:45 – Nora’s research – How the ACA has impacted contraceptive usage 24:00 – does contraceptive use save insurers money? 28:00 – paying for care specific to women’s health 35:00 – does being a mother change perspective on these issues? 38:45 – having your research tweeted by Obama, and the perils of your research becoming political and/or misinterpreted 47:30 – the fickle nature and frustrations of dedicating your life to researching health policy 54:00 – how we think about and frame healthcare spending 58:00 – how do you convince people it’s good to pay for other people’s health care? Links: Nora's Old Bio https://hcmg.wharton.upenn.edu/profile/norab/ List of Essential Health Benefits https://www.healthcare.gov/coverage/what-marketplace-plans-cover/ The Oregon Medicaid Health Insurance Experiment https://en.wikipedia.org/wiki/Oregon_Medicaid_health_experiment Her Papers http://content.healthaffairs.org/content/34/7/1204.abstract Coverage of Her Work https://ldi.upenn.edu/new-penn-contraceptives-and-aca-study-gets-wide-media-pickup http://www.npr.org/sections/health-shots/2015/07/08/421140260/women-are-saving-money-thanks-to-expanded-birth-control-coverage https://www.cnbc.com/2015/07/07/birth-controls-big-cost-control-gains-from-obamacare.html https://www.nytimes.com/2015/07/08/health/after-health-care-act-sharp-drop-in-spending-on-birth-control.html Wharton Healthcare Management site https://hcmg.wharton.upenn.edu/

Episode 4 - Dr. Debbie Kelly, Leaving Clinical Practice for Industry, and Spark Therapeutics Jul 20, 2017

Show notes

Dr. Debbie Kelly joins us to speak about her career, and the decision to leave clinical practice to work in pharma. Map: 5:30 – finding ophthalmology 9:45 – things that she didn’t like about clinical practice 12:30 – learning about GSK, industry, and the options for MD’s 21:00 – shifting to Pharmacovigilance 28:30 – getting contacted by the headhunter and going to Spark 34:15 – mulling the decision to leave clinical practice 45:00 – choosing one path vs. the unknown 51:00 – finding work-life balance in medicine and in industry 54:30 – challenges of pioneering gene therapy development Links: LinkedIn https://www.linkedin.com/in/deborah-kelly-47963922/ Pharmacovigilance https://en.wikipedia.org/wiki/Pharmacovigilance Spark Therapeutics http://sparktx.com/ Lancelot the Dog http://www.blindness.org/glossary/lancelot

Episode 3 - Ryan Littman-Quinn, mHealth, and Botswana Jul 20, 2017

Show notes

Ryan Littman-Quinn tells us about how he became an mHealth expert, and the challenges of overseeing successful projects abroad in Botswana and other African countries. Map: 5:20 – reaching out to click diagnostics and taking the job as graphic designer 8:20 – going to Botswana 14:00 – what is mHealth? 21:00 - working for the UPenn Botswana partnership 27:00 – Ryan’s first project – mLearning to support medical education 32:00 – challenges in mHealth projects and learning on the job 38:30 – Peak Vision 51:00 – Funding projects that are mix of entrepreneurship and non-profit Links: LinkedIn Profile https://www.linkedin.com/in/ryanlittmanquinn/ The Botswana-UPenn Partnership http://www.med.upenn.edu/botswana/ Andrew Bastawrous TED Talk https://www.ted.com/talks/andrew_bastawrous_get_your_next_eye_exam_on_a_smartphone Peek Vision Website https://www.peekvision.org/ Lancet Paper Framing the Need for Vision Care http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(17)30293-0/fulltext

Episode 2 - Dr. Kovarik and Teledermatology Jul 20, 2017

Show notes

Dr. Kovarik tells us about her career, and how she became a leader in the teledermatology field. Note: In the intro, I mistakenly said that the Accessderm Platform was rolled out both in Philly and Africa. It is a U.S only platform. Other local platforms are used in Africa. Map: 5:22 - Finding Dermatology at Baylor 8:39 - The beginning of telederm 12:20 - Becoming a leader in the field 14:45 - Issues in Derm field – shortage, long wait times, etc. and how telederm helps solve them 22:00 - Barriers to the growth of teledermatology 37:30 - Aligning incentives 44:00 - Limitations of teledermatology Links: Dr. Kovarik Profile https://www.pennmedicine.org/providers/profile/carrie-kovarik Her Twitter https://twitter.com/carriekovarik?lang=en Penn Med Teledermatology http://healthcareinnovation.upenn.edu/projects/teledermatology AlJazeera Article http://america.aljazeera.com/articles/2013/10/17/teledermatology-helpspeoplefrommalawitophilly.html

Episode 1 - Dr. Fajgenbaum, Castleman Disease, and the CDCN Feb 21, 2017

Show notes

We kick off the Penn Health-X Podcast with Dr. Fajgenbaum! Map 4:30 – football at Georgetown, his mother’s illness, and starting AMF 8:45 – getting to Penn Med and being diagnosed with Castleman Disease 13:40 – relapsing, and not being content with the state of research 17:20 – mentors, the orphan disease center, and starting the CDCN with an email 21:00 – getting the MBA and learning to manage a group of researchers 23:30 – learning to negotiate 24:50 – how biomedical research funding needs to change 31:00 – using the CDCN model for other orphan diseases 34:00 – thoughts on high drug prices, right-to-try legislation, and FDA regulation, and off-label use 39:55 – being compared to a Nobel Prize winner, and planning for another potential relapse 43:45 – final thoughts Links: LinkedIn Profile https://www.linkedin.com/in/davidfajgenbaum/ NYTimes Article: https://www.nytimes.com/2017/02/04/business/his-doctors-were-stumped-then-he-took-over.html Actively Moving Forward (AMF): https://healgrief.org/actively-moving-forward/ CDCN Website: http://www.cdcn.org/ Getting More by Stuart Diamond https://www.amazon.com/Getting-More-Negotiate-Succeed-Work/dp/0307716902 The Castle Man Image http://files.www.cdcn.org/3590_SketchWarrior-process-s312x341.jpg

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected